In a large measure thanks to the efforts of Longevity advocacy organizations, including the Global Healthspan Policy Institute, Israeli Longevity Alliance, Vetek Association and others, there is now included a special section on aging-related research and development into the US bill “H.R.1837 – United States-Israel Cooperation Enhancement and Regional Security Act” allocating 2 Million USD per year for 3 years for cooperation in aging-related R&D. According to the bill Section 110, Paragraph “I”

https://www.congress.gov/bill/116th-congress/house-bill/1837/text 

“There are authorized to be appropriated to the Secretary of Health and Human Services $2,000,000 for each of fiscal years 2020, 2021, and 2022 to establish a bilateral cooperative program with Israel for the development of health technologies, including health technologies described in paragraph (2), with an emphasis on collaboratively advancing the use of technology, personalized medicine, and data in relation to aging. …”

The bill passed the House of Representatives and was received in the Senate on July 24, 2019.

This is still a bill, but a good progress, showing the capability and value of dedicated longevity advocacy to bring tangible support for the longevity field.

Thank you for your further support of longevity research and advocacy!